Average Co-Inventor Count = 10.14
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (25 from 2,405 patents)
2. Schering Corporation (19 from 1,829 patents)
3. Dendreon Corporation (5 from 53 patents)
4. Other (1 from 832,843 patents)
5. Idenix Pharmaceuticals, Inc. (1 from 100 patents)
6. Merck Gmbh (1 from 17 patents)
7. Msd International Gmbh (1 from 7 patents)
8. Merck Sharp & Dohme LLC (1 from 6 patents)
48 patents:
1. 12497362 - Cyclopentapyrrole orexin receptor agonists
2. 12331018 - Pyrrolidine orexin receptor agonists
3. 12312332 - Heteroaryl pyrrolidine and piperidine orexin receptor agonists
4. 11730748 - Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseases
5. 11680060 - Bicycloheptane pyrrolidine orexin receptor agonists
6. 11098029 - 5-alkyl pyrrolidine orexin receptor agonists
7. 10899788 - Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseases
8. 10508108 - Tricyclic compounds as inhibitors of mutant IDH enzymes
9. 10442819 - Tricyclic compounds as inhibitors of mutant IDH enzymes
10. 10399972 - Tricyclic compounds as inhibitors of mutant IDH enzymes
11. 10086000 - Tricyclic compounds as inhibitors of mutant IDH enzymes
12. 9765107 - Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
13. 9732111 - 2'-alkynyl substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
14. 9637493 - Substituted pyrrolopyrimidines as HDM2 inhibitors
15. 9540377 - 2,6,7,8 substituted purines as HDM2 inhibitors